Bayer | BAYN - Net Income


Bayer reported EUR2.76B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Air Liquide EUR 1.72B 84.3M Dec/2025
Akzo Nobel EUR 93M 505M Mar/2026
Alcon AG USD 189M 28M Mar/2026
Amarin USD -1.22M 6.51M Dec/2025
Arkema EUR 27.2M 119.2M Mar/2026
AstraZeneca USD 3.08B 754M Mar/2026
BASF EUR 927M 367M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Beiersdorf EUR 387M 165M Dec/2025
Corteva USD 720M 1.27B Mar/2026
Covestro EUR -378M 331M Dec/2025
Essilor EUR 928M 459M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 118M 209M Mar/2026
Genmab DKK 31M 370M Dec/2025
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GRIFOLS EUR 73M 25.25M Mar/2026
Henkel EUR 925M 185M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Johnson Matthey GBP -78M 60M Jun/2026
Linde USD 1.86B 327M Mar/2026
Lonza CHF 426M 119M Jun/2025
Merck EUR 659M 340M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Nutrien USD 131M 440M Mar/2026
Philips EUR 151M 244M Mar/2026
PPG Industries USD 300M 153M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
SAP EUR 1.93B 86M Mar/2026
Solvay EUR 26M 121M Mar/2026
UCB EUR 1.08B 608M Dec/2025
Umicore EUR 247.85M 111.15M Dec/2025
Vinci EUR 3.01B 1.11B Dec/2025